(RTTNews) - Bio-Techne (TECH), a life science company, on Friday announced the launch of a new line of AI-engineered designer proteins aimed at advancing cell therapy and regenerative medicine. The ...

MINNEAPOLIS, April 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of cutting-edge life science tools, today announced an Early Access Program for its latest ...

MINNEAPOLIS, July 8, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the launch of new additions ...

TECH heads into fiscal fourth-quarter earnings with revenues expected to remain flat, EPS projected to decline, and its $11.3 ...

May 7 (Reuters) - Bio-Techne (TECH.O), opens new tab on Wednesday beat Wall Street estimates for third-quarter profit, driven by growth in its unit that provides proteins, antibodies and other ...

Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, pharmaceutical, diagnostics and bioprocessing markets worldwide. In 2013, Bio-Techne ...

German drugmaker Merck ​KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade.

Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota ...

Bio-Techne Corporation TECH is set to release first-quarter fiscal 2026 results on Nov. 5, before the opening bell. The life science and diagnostic product maker posted adjusted earnings per share ...

Bio-Techne introduces expanded R&D Systems AI-Engineered Designer Protein Portfolio: Minneapolis Thursday, July 9, 2026, 09:00 Hrs [IST] Bio-Techne Corporation, a global provider ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...